Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 18/20 | 0.51 |
| ▸ | CA4 | P22748 | 3/20 | 0.48 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8950419 | 0.79 | CA2 (0.52) | CA2CA4CA1CA9CA12 | |
| SCHEMBL9247300 | 0.78 | CA2 (0.49) | CA2CA4CA1CA9CA12 | |
| Hydrochloric Acid SCHEMBL8950431 | 0.78 | CA2 (0.51) | CA2CA4CA1CA9CA12 | |
| SCHEMBL8950067 | 0.76 | CA2 (0.58) | CA2CA4CA1CA9CA12 | |
| SCHEMBL9251357 | 0.75 | CA2 (0.39) | CA2CA4CA1CA9CA12 | |
| SCHEMBL8950571 | 0.75 | CA2 (0.65) | CA2CA4CA1CA9CA12 | |
| Hydrochloric Acid SCHEMBL8950440 | 0.74 | CA2 (0.64) | CA2CA4CA1CA9CA12 | |
| SCHEMBL8950408 | 0.72 | CA2 (0.62) | CA2CA4CA1CA9CA12 | |
| SCHEMBL8950256 | 0.72 | CA2 (0.64) | CA2CA4 | |
| Hydrochloric Acid SCHEMBL8950254 | 0.72 | CA2 (0.61) | CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5464831-A | Treatment of glaucoma | ALCON LABORATORIES, INC. (US) | 1995-11-07 | — | — | US | disclosed |